HUMA logo

Humacyte, Inc. Common Stock

HUMA

HUMA: Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

more

Show HUMA Financials

All
Government
Consumer Interest
SEC Filings
ESG/Other

Recently reported changes by institutional investors

Quarterly net insider trading by HUMA's directors and management

Government lobbying spending instances

  • $10,000 Apr 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $10,000 Oct 20, 2021 Issue: Medicare/Medicaid
  • $50,000 Jul 20, 2021 Issue: Medicare/Medicaid
  • $50,000 Apr 20, 2021 Issue: Medicare/Medicaid
  • $50,000 Jan 21, 2021 Issue: Medicare/Medicaid
  • $50,000 Oct 20, 2020 Issue: Medicare/Medicaid
  • $50,000 Jul 20, 2020 Issue: Medicare/Medicaid
  • $50,000 Apr 24, 2020 Issue: Medicare/Medicaid
  • $50,000 Apr 20, 2020 Issue: Medicare/Medicaid
  • $50,000 Oct 21, 2019 Issue: Medicare/Medicaid
  • $50,000 Jul 22, 2019 Issue: Medicare/Medicaid
  • $50,000 Apr 22, 2019 Issue: Medicare/Medicaid
  • $50,000 Jan 22, 2019 Issue: Medicare/Medicaid
  • $50,000 Oct 22, 2018 Issue: Medicare/Medicaid
  • $50,000 Jul 20, 2018 Issue: Medicare/Medicaid
  • $50,000 Apr 20, 2018 Issue: Medicare/Medicaid
  • $50,000 Jan 22, 2018 Issue: Medicare/Medicaid
  • $50,000 Oct 20, 2017 Issue: Medicare/Medicaid
  • $20,000 Jul 20, 2017 Issue: Medicare/Medicaid
  • $30,000 Jul 20, 2017 Issue: Medicare/Medicaid
  • $40,000 Apr 20, 2017 Issue: Medicare/Medicaid
  • $40,000 Jan 23, 2017 Issue: Medicare/Medicaid
  • $40,000 Oct 20, 2016 Issue: Medicare/Medicaid
  • $40,000 Jul 20, 2016 Issue: Medicare/Medicaid
  • $40,000 Apr 20, 2016 Issue: Medicare/Medicaid
  • $40,000 Jan 19, 2016 Issue: Medicare/Medicaid
U.S. Patents

New patents grants

  • Patent Title: Tubular prostheses Jul. 13, 2021
  • Patent Title: Tissue-engineered constructs Mar. 16, 2021
  • Patent Title: Tissue-engineered constructs Mar. 02, 2021
  • Patent Title: Methods and apparatuses for forming fibrous tubes Jul. 30, 2019
  • Patent Title: Tubular prostheses Jan. 08, 2019
  • Patent Title: Tubular tissue-engineered constructs May. 23, 2017
  • Patent Title: Tissue-engineered constructs May. 16, 2017
  • Patent Title: Tissue-engineered constructs Jan. 31, 2017
  • Patent Title: Compositions and methods for soft tissue augmentation Jun. 12, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of HUMA in WallStreetBets Daily Discussion

HUMA News

Recent insights relating to HUMA

CNBC Recommendations

Recent picks made for HUMA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in HUMA

Corporate Flights

Flights by private jets registered to HUMA